Penicillin G Injectable (Iv, Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV, IM)
Available Strengths: 1, 10, 20 million units / vial
Reference Brands: Generics only
Category:
Antibiotics
Penicillin G inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis and death. It is effective against severe infections like meningitis and pneumonia. Benefits include rapid bacterial eradication, proven efficacy, and safety when used appropriately, making it essential for treating life-threatening bacterial infections.
Penicillin G Injectable (IV, IM) is available in Injectable (IV, IM)
and strengths such as 1, 10, 20 million units / vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Penicillin G Injectable (IV, IM) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Penicillin G Injectable (IV, IM) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Penicillin G tablets are approved in the EU and US for treatment of severe bacterial infections, including meningitis, syphilis, and pneumonia. In the EU, these are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with biosimilar and generic options available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate market access for Penicillin G, ensuring adherence to European and American standards for safe, effective antibiotic delivery.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing